ArticleInternational journal of molecular sciences2021

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.

Ming-Huei Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.